June 24, 2015
UC Davis is stimulating innovative, collaborative brain research with a new program offering funding for projects with strong potential to lead to impactful discoveries.
May 12, 2015
Surgeons at UC Davis Health System are testing an innovative method of limiting cognitive decline in patients with Parkinson’s disease. The treatment — deep brain stimulation, or DBS — involves delivering low levels of electrical stimulation to a part of the brain that controls the abilities to think, plan and remember.
May 11, 2015
On April 15, 2015, three UC Davis leaders in research joined more than forty scientists from across the University of California (UC) system and representatives from the biomedical industry to discuss plans for strengthening UC’s position in drug, device and diagnostics development.
April 27, 2015
UC Davis investigators have settled a long-standing controversy surrounding the molecular basis of an inherited disorder that historically affected Ashkenazi Jews from Eastern Europe but now also arises in other populations of Semitic descent, particularly families from Saudi Arabia.
April 16, 2015
The UC Davis Alzheimer's Disease Center, one of only 27 research centers designated by the National Institutes of Health's National Institute on Aging, has established a new clinic in the East Bay in Walnut Creek.
April 15, 2015
David A. Bennett, director of the Rush University Alzheimer's Disease Center, will discuss "Reducing Your Risk for Alzheimer's Disease: Building a Better Brain as We Age," during the May UC Davis Alzheimer's Disease Center Community Engagement Lecture Series presentation.
March 26, 2015
UC Davis will establish a prestigious, leading-edge center to advance innovative research into the origins of schizophrenia: A Silvio O. Conte Center for Basic or Translational Mental-Health Research, one of only 15 such centers in the United States.
Alzheimer's Disease Center lecture explores connections between diabetes, heart disease and dementia
March 18, 2015
"Heart Disease, Diabetes and Dementia, What is the Connection?" will be the topic of the UC Davis Alzheimer's Disease Center 2015 Community Discovery lecture by center Associate Director Bruce Reed.
Commentary says study affirms that varied factors contribute to cognitive decline throughout adulthood
March 16, 2015
A study published online today in JAMA Neurology that finds associations between reduced hippocampal volume (HVa) and being male, but not the gene APOE ɛ4, suggests that there are multiple factors contributing to cognitive decline throughout adulthood, according to an accompanying commentary by UC Davis Alzheimer's Disease Center Director Charles DeCarli.
March 3, 2015
Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells – responsible for a usually fatal type of brain cancer – and could be applicable to other highly aggressive cancers.
February 27, 2015
The UC Davis Huntington’s Disease Center, whose compassionate patient care and research expertise have made it a beacon of hope for people with Huntington’s disease throughout Northern California and beyond, has been acknowledged by the national society committed to the values that it so ably upholds the Huntington’s Disease Society of America — as a Level 1 Huntington’s Disease Center of Excellence.
February 10, 2015
A new compound discovered by a team of UC Davis investigators has potent actions against production of a chemical that is implicated in the development of chronic pain following a peripheral nerve injury in the spinal cord.
December 1, 2014
Disparities in mental-health treatment are known to be associated with patients’ racial and ethnic backgrounds. Now, a large study by researchers with UC Davis has found one possible reason for those disparities: Racial and ethnic minorities are less likely to be assessed and referred for treatment by their medical providers.
November 12, 2014
In its first clinical application in pediatric patients, an investigational medication developed and manufactured at UC Davis has been found to effectively treat children with life-threatening and difficult-to-control epileptic seizures without side effects, according to a research report by scientists at UC Davis and Northwestern University.
UC Davis MIND Institute researchers to establish new tests to evaluate cognitive growth in people with intellectual disability
October 30, 2014
Researchers with the UC Davis MIND Institute will develop and evaluate tests designed to measure and track changes in the cognitive functioning of people who typically are difficult to assess accurately: those with an intellectual disability, formerly termed mental retardation. The research will be funded through a new, five-year, $3.2 million grant from the National Institutes of Health (NIH).
October 27, 2014
Kay Redfield Jamison, Dalio Family Professor in Mood Disorders and co-director of the Mood Disorders Center at the Johns Hopkins School of Medicine, will discuss "Professional and Personal Perspectives on Bipolar Illness," during a lecture on Thursday, Nov. 6, at 5 p.m. in the auditorium of the UC Davis MIND Institute, 2825 50th St.
October 20, 2014
The UC Davis Alzheimer’s Disease Center will hold a workshop for those caring for individuals with Alzheimer’s disease and dementia. The workshop will be held from 8 a.m. to 12:30 p.m. Saturday, Nov. 15, in the auditorium of the UC Davis MIND Institute, 2825 50th St., Sacramento. There is no cost to participate in the workshop; however, reservations are required to attend.
September 30, 2014
Two UC Davis research teams developing transformational technologies to understand the dynamics of the neural circuitry underlying behavior and cognition have received awards from the federal Brain Research through Advancing Innovative Technologies (BRAIN) Initiative, a presidential grand Challenge enterprise.
September 24, 2014
The UC Davis Comprehensive Cancer Center’s Brain Innovation Group has received a grant from the National Cancer Institute (NCI) to improve brain cancer surgery and treatment using UC Davis-developed biophotonic technology.
September 12, 2014
In what may be the largest study of sleep problems among individuals with multiple sclerosis (MS), researchers at UC Davis have found that widely undiagnosed sleep disorders may be at the root of the most common and disabling symptom of the disease: fatigue.
August 28, 2014
Autism is far more common in boys than girls - affecting 1 in 54 boys and 1 in 252 girls — but little is known about biological differences between boys and girls with autism. A new study, called the ‘Girls with Autism — Imaging of Neurodevelopment’ or GAIN Study, led by researchers at the UC Davis MIND Institute will explore those differences in very young girls with autism.